SHOP

Home
Product
- IMMUNOHISTOCHEMISTRY
- INSTRUMENT
- MOLECULAR
  - CISH
  - SUPER-ISH™
  - FISH
  - CONSUMABLES
- HISTOLOGY
  - H&E STAINS
  - SPECIAL STAINS
- CYTOLOGY
- DIGITAL PATHOLOGY
  - DIGITAL SCANNER
Solution
Support
About
Contact
- U.S.A
- CHINA

Home

Solution

Solution

Unraveling Thyroglobulin Antibody: A Clinical Guide

Unraveling Thyroglobulin Antibody: A Clinical Guide

Thyroglobulin antibody serves as a crucial marker for autoimmune thyroid disease, the primary cause of hypothyroidism and hyperthyroidism in the United States.

Enhancing Bladder Cancer Care: The Role of Immunohistochemistry Biomarkers in Diagnosis and Management

Enhancing Bladder Cancer Care: The Role of Immunohistochemistry Biomarkers in Diagnosis and Management

Bladder cancer remains a significant health concern worldwide, with a substantial impact on both men and women. Accurate diagnosis and effective management are critical for improving patient outcomes. In this blog, we explore the vital role of immunohistochemistry (IHC) biomarkers in bladder cancer, highlighting both established and emerging markers that are shaping the future of cancer diagnostics and treatment.

Unraveling the Mystery of Primary and Secondary Antibodies: What You Need to Know

Unraveling the Mystery of Primary and Secondary Antibodies: What You Need to Know

Antibodies, also known as immunoglobulins, are essential proteins produced by the immune system to defend the body against harmful invaders. These microscopic defenders play a crucial role in identifying and neutralizing foreign substances such as bacteria and viruses. There are five main types of antibodies, each with specific functions: IgG, IgM, IgA, IgD, and IgE.

Unveiling the Power of Molecular Diagnostics: A Comprehensive Guide

Unveiling the Power of Molecular Diagnostics: A Comprehensive Guide

Molecular diagnostics is a cutting-edge field that plays a pivotal role in modern medicine. It involves analyzing DNA and RNA to uncover valuable insights into genetic information, diseases, and personalized treatments. The global molecular diagnostics market has experienced substantial growth, with a projected value of USD 61.29 billion by 2033 at a CAGR of 3.8% from 2024 to 2033.